The prognostic and predictive impact of low estrogen receptor expression in early breast cancer: a systematic review and meta-analysis.

Paakkola, N-M; Karakatsanis, A; Mauri, D; Foukakis, T; Valachis, A

Paakkola, N-M; Karakatsanis, A; Mauri, D; Foukakis, T; Valachis, A.

Afiliación

Paakkola NM; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Karakatsanis A; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Mauri D; Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Foukakis T; Department of Oncology-Pathology, Karolinska Institutet Stockholm, Stockholm, Sweden.
Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. Electronic address: antonios.valachis@oru.se.

ESMO Open ; 6(6): 100289, 2021 12.

Article en En | MEDLINE | ID: mdl-34678571

Asunto(s)

Neoplasias de la Mama; Receptores de Estrógenos; Neoplasias de la Mama/tratamiento farmacológico; Femenino; Humanos; Pronóstico; Estudios Prospectivos; Receptores de Estrógenos/uso terapéutico; Estudios Retrospectivos

Palabras clave

ER-low; adjuvant; breast cancer; meta-analysis; neoadjuvant chemotherapy; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Estrógenos Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: ESMO Open Año: 2021 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google